Advertisement
Review Article| Volume 32, ISSUE 3, P697-704, September 2005

Download started.

Ok

Diagnosis and Management of Human Parvovirus B19 Infection

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Perinatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cossart Y.E.
        • Field A.M.
        • Cant B.
        • et al.
        Parvovirus-like particles in human sera.
        Lancet. 1975; 1: 72-73
        • Isada N.B.
        • Berry S.M.
        In utero diagnosis of congenital infection.
        in: Gonik B. Viral diseases in pregnancy. Springer-Verlag, New York1994: 34-49
        • Practice Bulletin ACOG
        Perinatal viral and parasitic infections.
        Number. 2000; 20: 2-13
        • Chisaka H.
        • Morita E.
        • Yaegashi N.
        • et al.
        Parvovirus B19 and the pathogenesis of anaemia.
        Rev Med Virol. 2003; 13: 347-359
        • Murphy J.
        • Jones D.C.
        Managing the gravida with parvovirus.
        OBG Management. 2000; Nov: 1-7
        • Valeur-Jensen A.K.
        • Pedersen C.B.
        • Westergaard T.
        • et al.
        Risk factors for parvovirus B19 infection in pregnancy.
        JAMA. 1999; 281: 1099-1105
        • Brown T.
        • Anand A.
        • Ritchie L.D.
        Intrauterine parvovirus infection associated with hydrops fetalis.
        Lancet. 1984; 2: 1033-1034
        • Corcoran A.
        • Doyle S.
        Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19.
        J Med Microbiol. 2004; 53: 459-475
        • Cooling L.L.
        • Koerner T.A.
        • Naides S.J.
        Multiple glycosphingolipids determine the tissue tropism of parvovirus B19.
        J Infect Dis. 1995; 172: 1198-1205
        • Torok T.J.
        • Qi-Yun W.
        • Gary Jr, W.
        • et al.
        Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction.
        Clin Infect Dis. 1992; 14: 149-155
        • Hager J.H.
        • Alder S.P.
        • Koch W.C.
        • et al.
        Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risk and symptoms.
        Obstet Gynecol. 1998; 91: 412-420
        • Young N.S.
        Parvoviruses.
        in: Fields B.N. Knipe B.N. Howley P.M. Field's virology. 3rd edition. Lippincott-Raven, Philadelphia1996: 2199-2220
        • Jordan J.A.
        Appreciating the differences between immunoassays used to diagnose maternal parvovirus B19 infection: understanding the antigen before interpreting the results.
        Prim Care Update Ob Gyns. 2002; 9: 154-159
        • Doyle S.
        • Kerr S.
        • O'Keefe G.
        • et al.
        Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis.
        J Virol Methods. 2000; 90: 143-152
        • Musiani M.
        • Zerbini M.
        • Gentilomi G.
        • et al.
        Parvovirus B19 clearance from peripheral blood after acute infection.
        J Infect Dis. 1995; 172: 1360-1363
        • Gillespie S.M.
        • Cartter M.L.
        • Asch S.
        • et al.
        Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiousum.
        JAMA. 1990; 263: 2061-2065
        • Kock W.C.
        • Adler S.P.
        Human parvovirus B19 infections in women of childbearing age and within families.
        Pediatr Infect Dis J. 1989; 8: 83-87
        • Cohen B.J.
        • Buckley M.M.
        The prevalence of antibody to human parvovirus B19 in England and Wales.
        J Med Microbiol. 1988; 25: 151-153
        • Cosmi E.
        • Mari G.
        • Chiaie L.D.
        • et al.
        Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection.
        Am J Obstet Gynecol. 2002; 187: 1290-1293
        • Nunoue T.
        • Kusuhara K.
        • Hara T.
        Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence, and fetal prognosis.
        Pediatr Infect Dis J. 2002; 21: 1133-1136
        • Miller E.
        • Fairly C.K.
        • Cohen B.J.
        • et al.
        Immediate and long term outcome of human parvovirus B19 infection in pregnancy.
        Br J Obstet Gynaecol. 1998; 106: 174-178
        • Norbeck O.
        • Papadogiannakis N.
        • Petersson K.
        • et al.
        Revised clinical presentation of parvovirus B19-associated intrauterine fetal death.
        Clin Infect Dis. 2002; 35: 1032-1038
        • Rodis J.F.
        • Borgida A.F.
        • Wilson M.
        • et al.
        Management of parvovirus infection in pregnancy and outcome of hydrops: a survey of members of the Society of Perinatal Obstetricians.
        Am J Obstet Gynecol. 1998; 179: 985-988
        • Hedrick J.
        The effects of human parvovirus B19 and cytomegalovirus during pregnancy.
        J Perinat Neonatal Nurs. 1996; 10: 30-39
        • Moise K.J.
        Management of rhesus alloimmunization in pregnancy.
        Obstet Gynecol. 2002; 100: 600-611
        • Humphrey W.
        • Maggon M.
        • O'Shaughnessy R.
        Severe nonimmune hydrops secondary to parvovirus B-19 infection: Spontaneous reversal in utero and survival of a term infant.
        Obstet Gynecol. 1991; 78: 900-902
        • Fairly C.K.
        • Smolenic J.S.
        • Caul O.E.
        • et al.
        Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvo B19 infection.
        Lancet. 1995; 346: 1335-1337